Microbiome, Inflammation and Cancer

Similar documents
Page 1. Is the Risk This High? Dysplasia in the IBD Patient. Dysplasia in the Non IBD Patient. Increased Risk of CRC in Ulcerative Colitis

IBD high risk groups

Gut Microbiota and IBD. Vahedi. H M.D Associate Professor of Medicine DDRI

The enteric microbiota: Implications for IBD. Eugene B. Chang, M.D. University of Chicago

IBD and Cancer: Myths and Facts

Diagnostic and Therapeutic Approaches to Dysplasia in Inflammatory Bowel Diseases

Microbiome GI Disorders

Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease

CRC and Dysplasia in IBD: Objectives of Talk. Colorectal Cancer and Dysplasia in IBD: A Case-Based Approach. Page 1

Gut Lung Axis Implication of the Gut Microbiota beyond its niche

4/17/2019 DISCLOSURES OBJECTIVES GI MICROBIOME & HEALTH: A REVIEW. Nancy C. Kois, MD, FCAP Contemporary Pathology Services. There are no disclosures

Diagnostic techniques for surveillance of dysplasia

Update in Pediatric IBD: 2018

New and Emerging Therapies in IBD. Sarah Streett MD, AGAF Clinical Associate Professor of Medicine Stanford University

THE ROLE OF MICROBIOME IN IBD

Can We Predict the Natural History of Ulcerative Colitis? Edward V Loftus, Jr, MD Professor of Medicine Mayo Clinic Rochester, Minnesota, USA

The A, B, C s of Bowel Flora

Slide 1. Slide 2 Learning outcomes. Slide 3. Year 1 MBChB Lecture 15 Introduction to the Gut Microbiota. The importance of microbiota

The number of microorganisms residing in our intestines is 10 times the number of our somatic and germ cells.

Cancer Risk with IBD Therapies How to Discuss with your Patients?

Resistant Starch for a Healthy Gut

Issues at Hand. Inflammatory Bowel Disease Paradigm. Diet changes the fecal microbiome. Experience with diet in IBD

BUTYRATE PRODUCING BACTERIA AS PROBIOTIC TREATMENT IN IBD

Is there an anti-inflammatory diet in IBD?

New Insights on the Structure of the Human Gut Microbiota. Chaysavanh Manichanh, PhD Vall d Hebron Research Institute Barcelona

Chromoendoscopy and Endomicroscopy for detecting colonic dysplasia

Intestinal Microbiota in Health and Disease

Ulcerative Colitis: Refining our Management and Incorporating Newer Concepts

AAIM: GI Workshop Follow Up to Case Studies. Non-alcoholic Fatty Liver Disease Ulcerative Colitis Crohn s Disease

Fecal Microbiota Transplantation for Severe sepsis and Diarrhea : a Case Report

HOW THE MICROBIOME AFFECTS OUR HEALTH

17 th International Conference of the Inflammation Research Association: Wednesday AM (Day 4) September 9-13, 2012

Novel Optical Research at UPMC

Accepted Manuscript. Does eradication of Helicobacter pylori cause inflammatory bowel disease? Johan Burisch, Tine Jess

Clinically proven to quickly relieve symptoms of common gastrointestinal disorders. TERRAGASTRO - Good health starts in the gut

Chromoendoscopy or Narrow Band Imaging with Targeted biopsies Should be the Cancer Surveillance Endoscopy Procedure of Choice in Ulcerative Colitis

Learning Objectives:

Malignancy Risk in Pediatric IBD: What to tell parents and patients?

Microbiome in You: Optimizing Gut Bacteria for Better IBD Management

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

INFLAMMATORY BOWEL DISEASE. Jean-Paul Achkar, MD Center for Inflammatory Bowel Disease Cleveland Clinic

Latest Endoscopic Guidelines for FAP, HNPCC, IBD, and the General Population

What Have We Learned About the Microbiome in Pediatric IBD?

Etiology, Assessment and Treatment

Microbiome. A new dimension in Medicine. Israel De Alba, MD MPH. Clinical Professor

Microbiome as Predictor of Benefit and Toxicity in Cancer Immunotherapy

Colonic Polyp. Najmeh Aletaha. MD

Ali Keshavarzian MD Rush University Medical Center, Chicago, IL

Bibliografia Microbiota

The role of gut microbiome in IBS

Our microbiome: The role of vital gut bacteria, diet, nutrition and obesity

Dysbiosis & Inflammation

Personalized Medicine in IBD

HUMAN GUT MICROBIOTA

Module Outline. 1. Microbiome overview: getting a sense of the microbiome, research, what we know

How to characterize dysplastic lesions in IBD?

Icd 10 code for esophageal cancer stage 4

CASE DISCUSSION: The Patient with Dysplasia: Surgery or Active Surveillance? Noa Krugliak Cleveland, MD David T. Rubin, MD

Icd 10 code for esophageal cancer stage 4

Dysplasia 4/19/2017. How do I practice Chromoendoscopy for Surveillance of Colitis? SCENIC: Polypoid Dysplasia in UC. Background

Exosomes as a. Novel Therapeutic Approach to Gastrointestinal Diseases Rebecca Murray APRN, FNP, CDE

5-ASA and Carcinogenesis in IBD

How to Screen a patient with a Family History of Adenoma(s)

Bacteriology. Mycology. Patient: SAMPLE PATIENT DOB: Sex: MRN: Rare. Rare. Positive. Brown. Negative *NG. Negative

- A cancer is an uncontrolled, independent proliferation of robust, healthy cells.

PEDIATRIC INFLAMMATORY BOWEL DISEASE

Chromoendoscopy - Should It Be Standard of Care in IBD?

Stage 4 gastric adenocarcinoma icd 10

The Natural History of Right-Sided Lesions

Available Data on Pediatric Exposure Response a Clinician s Perspective

Implementation of disease and safety predictors during disease management in UC

The international health care burden of cancers of the gastrointestinal tract and liver

LIST OF ABBREVIATIONS

Surveying the Colon; Polyps and Advances in Polypectomy

The Gut Microbiota: Evidence For Gut Microbes as Contributors to Weight Gain

DISCUSSION GROUP #5 ISAPP 2014 THE MICROBIOME AND HEALTH: PROMISING ENDPOINTS FOR INTERVENTIONS. Friday, June 20, 2014

Functional Nutrition Approaches to Gut Health 20 CPEU Module accredited by Nutrition Mission

Personalized Aspirin Therapy

P A T I E N T H A N D B O O K

Beyond the Scope: An Integrative Gastroenterologist s Approach to Digestive Disorders

Probiotics in the ICU. Who could benefit? Nadia J van Rensburg RD(SA) Groote Schuur Hospital, Cape Town

The Gut Microbiome: 101 Justin Carlson University of Minnesota

Missed Lesions at Endoscopy. Dr Russell Walmsley, MD, FRCP, FRACP Gastroenterologist WDHB Chair Endoscopy Guidance Group for New Zealand

WEO CRC SC Meeting. Barcelona, Spain October 23, 2015

Good Bugs Bad Bugs: The Role of the Microbiome on Human Health

Looking for Answers. IBD Research March 9, Dr. Benjamin Click, MD MS Associate Staff Cleveland Clinic

12/1/2017. Disclosures. Objectives. The Microbiome Defined

ROLE OF THE GUT BACTERIA

Overview of the Microbiome in Health and Disease Cindy D. Davis

The vital role of the microbiome in human health

Type 2 Diabetes and Cancer: Is there a link?

NEURO- GASTRO- ENTEROLOGY & MOTILITY OESO- PHAGUS LOGY. Room A Room B Room C Room E1 Room E2 Room M Room N1 Room N2 Room L8 Room 1.

AGA Technical Review on the Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease

Faecalibacterium prausnitzii

MANAGEMENT OF BARRETT S RELATED NEOPLASIA IN 2018

Therapeutic Manipulation of the Gut Microbiota in Patients with IBD

7 th Annual GASTROENTEROLOGY AND HEPATOLOGY SYMPOSIUM LOCATION: Harbor Beach Marriott Fort Lauderdale, Florida

LET S TALK ABOUT CANCER

2017 NEEDS ASSESSMENT SURVEY

removal of adenomatous polyps detects important effectively as follow-up colonoscopy after both constitute a low-risk Patients with 1 or 2

Transcription:

Microbiome, Inflammation and Cancer Anita Afzali MD, MPH, FACG Medical Director, OSU Inflammatory Bowel Disease Center Abercrombie & Fitch Endowed Chair in Inflammatory Bowel Disease 4 th Annual Cancer Disparities Conference (CDC) March 10 th, 2018 Financial Disclosures Consultant/Speaker: Abbvie, UCB, Takeda, Janssen, Pfizer Grant/Clinical Trials Support: UCB, Abbvie, Janssen, Celgene, Takeda Board Member/Founder: IBD Horizons 1

Objectives Introduction to our microbiome Impact of diet and inflammation to the microbiome Effect of inflammation on cancer Review of inflammatory bowel disease and cancer We are More Bacteria than Human Healthy adult harbors ~100 trillion bacteria in gut alone This is 10X the number of human cells we possess Humans possess 23,000 genes Microbiome contributes ~3,300,000 Communal gut microbial genome (microbiome) is ~150 times larger than human genome 2

Microbiome, A Human Organ Reasonable to view microbiome as an organ Weighs ~1kg although is without distinct structure Organized system of cells more akin to immune system than liver Dominated by 4 large groups of bacteria or phyla: Actinobacteria Bacteroidetes Firmicutes Proteobacteria Development of Microbiota Tamburini S et al. Nat Med 2016 3

Development of the Microbiota Single Layer of Intestinal Epithelial Cells Separates Trillions of Bacteria from Lamina Propria 4

Coevolution of Host and Microbiome Evolutionary aligned interests and interplay neither wishes to harm Commensal bacteria provide benefits to host Expansion of Host Metabolic Capacity by Microbiome Bacteria express glycoside hydrolase converts glycans to useable sugars No enzyme encoded in human genome is capable of digesting glycans, only bacterial enzymes! Many carbohydrates are digestible only by bacteria -> SCFA Primary fuel for colonocytes 10-15% of adult energy may be generated by SCFA production, stored as fat 5

Sensing of Bacteria by Intestinal Epithelial Cells Abreu MT 2010 Importance of Host-Microbiome Alignment Microbiome may cause disease directly or indirectly, when this delicate balance is disturbed Many diseases may result from this dysregulation: Diabetes Obesity Metabolic syndrome Stress/anxiety Cardiovascular disease Rheumatologic diseases Inflammatory bowel disease (IBD) Cancer 6

Diet, Microbiome and Inflammation are Connected Microbiome = complex microbial community that inhabits GI tract, respiratory tract, skin Altered microbiota = Dysbiosis May be factor in perpetuation of inflammatory diseases Link Between Diet, TMAO and Microbiome, and CV Risk Omnivores produce more TMAO than vegans/vegetarians following ingestion of red meat-derived L-carnitine through microbiota-dependent mechanism Prevotella-rich microflora had higher plasma levels of TMAO -> greater risk of CV disease Koeth RA et al. Nat Med 2013 7

Rheumatic Diseases and Distinct Microbiomes Disease States PA, AS, RA Distinct microbiome Different cytokine profile Scher GU et al. Arthritis Rheum 2016 Role of Microbiome in IBD Gut microbiome - implicated in regulating intestinal adaptive immune responses Diet plays important role in intestinal immune function: Bacterial metabolites from fiber expand T reg cells in gut, may prevent High fats/sugar promote overgrowth of inflammatory bacterial species Smith PM et al. Science 2013 8

Differences in Microbiome associated with IBD Types of bacteria associated with UC/CD different than non-ibd Production of proinflammatory cytokines Distinct in UC vs CD Forbes JD et al. Inflamm Bowel Dis 2016 Inflammation is Critical Component of Tumor Progression Cancers can arise from sites of chronic irritation, inflammation Vital component of tumor microenvironment are inflammatory cells Inflammation promotes neoplastic processes involved in proliferation, survival, migration Tumor cells have co-opted inflammatory signaling molecules and receptors Tumors act as wounds that fail to heal 9

Microbial Influence in Inflammation and Cancer Fulbright LE et al. PLOS 2017 Cancers associated with Inflammatory States Inflammatory bowel disease Gastric intestinal metaplasia Barrett s esophagus Chronic hepatitis Chronic pancreatitis Oral leukoplasia Atypical adenomatous hyperplasia Ductal carcinoma in situ Prostatic intraepithelial neoplasia Bladder dysplasia Cervical dysplasia Actinic keratoses Colorectal cancer Gastric cancer Esophageal cancer Hepatocellular carcinoma Pancreatic cancer Head/neck cancer Non-small cell lung cancer Breast cancer Prostate cancer Bladder cancer Cervical cancer Skin cancer 10

Chronic Inflammation Promotes Cancer Insulted stromal cells recruit activated inflammatory cells Microbial (dysbiosis) triggers inflammatory cells - express factors that stimulate cell growth and progression Activated monocyte/macrophages Chronic activation promotes continued inflammation, angiogenesis, and ECM remodeling Promotion Malignant conversion mutation epithelial cells initiated epithelium benign carcinoma Modified from Dan Dixon, Univ South Carolina Inflammatory Bowel Disease and Colorectal Cancer 11

21 st Century: IBD is a Global Disease Incidence Crohn s Disease, 1990-2016 SC Ng. Lancet October 2017 21 st Century: IBD is a Global Disease Incidence Ulcerative Colitis, 1990-2016 SC Ng. Lancet October 2017 12

Chronic Inflammation is a Risk Factor for Cancer Normal Colon Ulcerative colitis Colon Adenocarcinoma Chronic Inflammation is a Risk Factor for Cancer Ulcerative colitis (UC) Chronic Inflammation Dysplasia Adenocarcinoma Patients with UC have a 5 to 7-fold greater risk of getting colon cancer UC persisting for 35-40 years increases the risk 20-35% Colon cancer associated with IBD has the worst prognosis Management with anti-inflammatory agents reduce incidence of cancer 13

Increased Colorectal Cancer Risk in IBD Large Population-based studies >1000 pts Overall, 2-3x risk for CRC Ekbom NEJM 1990, Lancet 1990 Soderlund GE 2009 Bernstein Cancer 2001 Disease Duration: Risk for CRC in Colitis Increases Over Time Cumulative probability (%) 25 20 15 10 5 1 UC 0 5 10 15 20 25 30 Time from diagnosis (years) Overall prevalence of CRC in any UC patient is 3.7% Eaden JA et al. Gut 2001 14

Disease Distribution: Anatomical Extent of Inflammation Increases Risk for CRC Meta-Analysis: Extensive Colitis SIR 6.4 (2.4-17.5) (3) Extensive Colitis SIR 4.8 (3.9-5.9) (4) 1. Ekbom NEJM 1990 2. Soderlund GE 2009 3. Lutgens IBD 2013 4. Jess CGH 2012 Family History: Increases Risk of CRC in IBD Patients Large population-based cohort study 19,876 UC or CD patients Results: First degree relative with CRC: RR 2.5 (1.4-4.4) First degree relative with CRC: <50 yrs: RR 9.2 (3.7-23) Askling, Gastroenterology 2001 15

Concomitant Inflammatory Diseases: Primary Sclerosing Cholangitis Increases Risk for CRC 5% of extensive UC patients 5% neoplasia risk (p <0.001) Colitis Duration PSC No PSC 10y 9% 2% 20y 31% 5% 25y 50% 10% Meta-analyses: Neoplasia OR 4.79 (3.58-6.41) CRC RR 9.13 (4.52-18.5) Broome, Hepatology 1995 Soetikno, GIE 2002 Jess, GE 2012 Severity of Inflammation: More mucosal inflammation increases risk for CRC An independent risk factor Case-control study (1) Significant effect of histological inflammation score (p<0.001) OR neoplasia 4.69 (95% CI 2.10-10.48; p<0.001) for each score unit increase Cohort study (2) Histological inflammation HR neoplasia 3.0 (95% CI 1.4-6.3) Macroscopically normal colonoscopy no inflammation (3) CRC risk over 5 yr period no higher than general population (age & sex matched) 1. Rutter, Gastro 2004 2. Gupta, Gastro 2007 3. Rutter, Gut 2004 16

Additional Factors: Increased Risk for CRC in IBD Post-inflammatory polyps = pseudopolyps OR 2.3-2.5 for neoplasia Suggests chronicity of inflammation Young age at diagnosis of IBD Meta-analysis of pop-based studies: Young age in UC SIR 8.6 (3.8-19.5) IBD Diagnosis < 30y SIR 7.2 (2.9-17.8) Absolute risk of CRC at young age remains low Probably not independent risk factor, but composite risk of: Disease duration ahead; extensive; more severe inflammation Men with UC had greater risk of CRC SIR 2.6 (2.2-3.0) Women SIR 1.9 (1.5-2.3) Rutter, Gut 2004 Velayos, Gastro 2006 Jess, CGH 2012 Lutgens, IBD 2013 The Power of the Microbiome All diseases begin in the gut. Hippocrates 17

Questions Free CME/CNE Registration: www.ibdhorizons.org 18